Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q2 2014 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.3% |
VANGUARD TOTAL STOCK MKT ETF | 12 | Q2 2023 | 82.1% |
SOMALOGIC INC | 9 | Q3 2023 | 3.4% |
BIONANO GENOMICS INC | 9 | Q4 2020 | 0.1% |
COMPASS THERAPEUTICS INC | 8 | Q3 2023 | 4.8% |
BIOMX INC | 8 | Q3 2021 | 0.0% |
AN2 THERAPEUTICS INC | 7 | Q3 2023 | 1.9% |
COLLIER CREEK HOLDINGS | 7 | Q2 2020 | 0.3% |
WHOLE EARTH BRANDS INC | 7 | Q4 2021 | 0.2% |
FINTECH ACQUISITION CORP III | 7 | Q3 2020 | 0.2% |
View Monashee Investment Management LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-05 |
13F-HR | 2023-02-09 |
13F-HR | 2022-11-01 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-07 |
13F-HR | 2021-11-09 |
View Monashee Investment Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.